Targeting Rare Diseases with Precision Medicine: The Rise of Somatostatin Analogs The global Somatostatin Analogs Market is witnessing steady expansion, valued at USD 5.2 billion in 2024, and projected to reach USD 8.9 billion by 2033, growing at a CAGR of 7.1% during the forecast period (2025–2033). As rare endocrine disorders and neuroendocrine tumors (NETs) gain more clinical and ... https://alignstrategicimperative.com/industry/somatostatin-analogs-market/